Former ADAC Labs executive Mohamed S. Elmandjra has taken the helm of Photonify Technologies, developer of a novel noninvasive medical imaging technology. The new president and CEO
Former ADAC Labs executive Mohamed S. Elmandjra has taken the helm of Photonify Technologies, developer of a novel noninvasive medical imaging technology. The new president and CEO of Photonify served ADAC as a senior vice president, as well as general manager of the PET division and vice president of marketing. Before that, Elmandjra worked eight years at GE Medical Systems, where he held various management positions in Europe and the U.S. Elmandjra will also serve on the board of directors for privately held Photonify, which is developing an optical spectroscopy product that may allow quantitative real-time imaging and oxygen mapping.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.